
|Videos|January 19, 2022
Future Studies and Implications for Dupilumab in Atopic Dermatitis
Future studies are necessary to continue evaluating the true benefits of dupilumab in conditions like atopic dermatitis.
Advertisement
Pharmacy Times spoke with Dr. Peter Lio, assistant professor of dermatology & pediatrics at Northwestern University Feinberg School of Medicine, about dupilumab associated Ocular Surface Disease in patients with atopic dermatitis.
Dr. Lio discussed how this approach has been different than previous studies about atopic dermatitis/conjunctivitis and future studies that are needed for dupilumab.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Obinutuzumab-Bendamustine Produces High Response Rates in Chinese Patients With Indolent B-Cell Lymphomas
2
Dosing, Monitoring, and Counseling: The Pharmacist's Role in TKI Therapy for Systemic Mastocytosis
3
New CKD Outcome Set Tells Pharmacists What to Measure
4
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
5





































































































